Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Reverse phenotyping in patients with skin capillary malformations and mosaic GNAQ or GNA11 mutations defines a clinical spectrum with genotype-phenotype correlation.

Jordan M, Carmignac V, Sorlin A, Kuentz P, Albuisson J, Borradori L, Bourrat E, Boute O, Bukvic N, Bursztejn AC, Chiaverini C, Delobel B, Fournet M, Martel J, Goldenberg A, Hadj-Rabia S, Mahé A, Maruani A, Mazereeuw J, Mignot C, Morice-Picard F, Moutard ML, Petit F, Pasteur J, Phan A, Whalen S, Willems M, Philippe C, Vabres P.

J Invest Dermatol. 2019 Nov 11. pii: S0022-202X(19)33390-1. doi: 10.1016/j.jid.2019.08.455. [Epub ahead of print] No abstract available.

PMID:
31726051
2.

Mucous membrane pemphigoid and lichenoid reactions after immune checkpoint inhibitors: common pathomechanisms.

Fässler M, Rammlmair A, Feldmeyer L, Suter VGA, Gloor A, Horn M, Deml K, Beltraminelli H, Borradori L.

J Eur Acad Dermatol Venereol. 2019 Oct 29. doi: 10.1111/jdv.16036. [Epub ahead of print]

PMID:
31660663
3.

Oral lichen planus and oral lichenoid lesions - an analysis of clinical and histopathological features.

Feldmeyer L, Suter VG, Oeschger C, Cazzaniga S, Bornstein MM, Simon D, Borradori L, Beltraminelli H.

J Eur Acad Dermatol Venereol. 2019 Sep 30. doi: 10.1111/jdv.15981. [Epub ahead of print]

PMID:
31568593
4.

Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry.

Cazzaniga S, Anzengruber F, Augustin M, Boehncke WH, Borradori L, Conrad C, Cozzio A, Djamei V, French LE, Gilliet M, Häusermann P, Heidemeyer K, Itin P, Kolios AGA, Laffitte E, Maul JT, Mainetti C, Naldi L, Navarini AA, Rustenbach SJ, Simon D, Sorbe C, Streit M, Yawalkar N.

J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2313-2318. doi: 10.1111/jdv.15983. Epub 2019 Oct 28.

PMID:
31562785
5.

Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.

Seyed Jafari SM, Gadaldi K, Feldmeyer L, Yawalkar N, Borradori L, Schlapbach C.

Front Immunol. 2019 Aug 14;10:1919. doi: 10.3389/fimmu.2019.01919. eCollection 2019.

6.

Ulceration and Alopecia of the Scalp Owing to C2 Radiculoneuropathy Following Posterior Atlanto-Axial Fixation.

Prenner A, Blum R, Bigdon SF, Borradori L.

JAMA Dermatol. 2019 Jul 3. doi: 10.1001/jamadermatol.2019.1115. [Epub ahead of print] No abstract available.

PMID:
31268474
7.

Mepolizumab failed to affect bullous pemphigoid: A randomized, placebo-controlled, double-blind phase 2 pilot study.

Simon D, Yousefi S, Cazzaniga S, Bürgler C, Radonjic S, Houriet C, Heidemeyer K, Klötgen HW, Kozlowski E, Borradori L, Simon HU.

Allergy. 2019 Jun 22. doi: 10.1111/all.13950. [Epub ahead of print] No abstract available.

PMID:
31230371
8.

Emergency Consultations in Dermatology in a Secondary Referral Hospital in Southern Switzerland: A Prospective Cross-Sectional Analysis.

Pelloni L, Cazzaniga S, Naldi L, Borradori L, Mainetti C.

Dermatology. 2019;235(3):243-249. doi: 10.1159/000498850. Epub 2019 Mar 28.

PMID:
30921799
9.

Mucous membrane pemphigoid of the oral lichen type: a retrospective analysis of 16 cases.

Benzaquen M, Suter VGA, Gschwend M, Feldmeyer L, Borradori L.

J Eur Acad Dermatol Venereol. 2019 May;33(5):e205-e207. doi: 10.1111/jdv.15473. Epub 2019 Mar 1. No abstract available.

PMID:
30720898
10.

Human "TH9" cells are a subpopulation of PPAR-γ+ TH2 cells.

Micossé C, von Meyenn L, Steck O, Kipfer E, Adam C, Simillion C, Seyed Jafari SM, Olah P, Yawlkar N, Simon D, Borradori L, Kuchen S, Yerly D, Homey B, Conrad C, Snijder B, Schmidt M, Schlapbach C.

Sci Immunol. 2019 Jan 18;4(31). pii: eaat5943. doi: 10.1126/sciimmunol.aat5943.

PMID:
30658968
11.

Pushing and loss of elastic fibers are highly specific for melanoma and rare in melanocytic nevi.

Stillhard A, Cazzaniga S, Borradori L, Beltraminelli H.

Arch Dermatol Res. 2019 Mar;311(2):99-107. doi: 10.1007/s00403-018-1885-x. Epub 2018 Dec 13.

PMID:
30547366
12.

Subacute cutaneous lupus erythematosus triggered by an antiviral treatment combination for hepatitis C virus infection.

Prenner A, Blum R, Beltraminelli H, Stirnimann G, Borradori L.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e129-e131. doi: 10.1111/jdv.15330. Epub 2018 Nov 26. No abstract available.

PMID:
30394571
13.

Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice.

Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, Drach M, Blome C, Boehncke WH, Thaci D, Reich K, von Kiedrowski R, Körber A, Yawalkar N, Mainetti C, Laffitte E, Streit M, Rustenbach S, Conrad C, Borradori L, Gilliet M, Cozzio A, Itin P, Häusermann P, French LE, Radtke MA, Augustin M.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):700-708. doi: 10.1111/jdv.15324. Epub 2019 Jan 15.

14.

Desmoplakin Gene Variants and Risk for Arrhythmogenic Cardiomyopathy.

Favre B, Begré N, Marsili L, van Tintelen JP, Borradori L.

Circ Genom Precis Med. 2018 Sep;11(9):e002241. doi: 10.1161/CIRCGEN.118.002241. No abstract available.

PMID:
30354334
15.

Prioritizing topics in guideline development: results of a two-phase online survey of dermatologist members of the EADV.

Nast A, Gaskins M, Eisert L, Werner RN, Borradori L, Marinovic B, Paul C, Dressler C.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):227-233. doi: 10.1111/jdv.15282. Epub 2018 Nov 13.

PMID:
30317678
16.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
17.

Desmoplakin interacts with the coil 1 of different types of intermediate filament proteins and displays high affinity for assembled intermediate filaments.

Favre B, Begré N, Bouameur JE, Lingasamy P, Conover GM, Fontao L, Borradori L.

PLoS One. 2018 Oct 4;13(10):e0205038. doi: 10.1371/journal.pone.0205038. eCollection 2018.

18.

Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid.

Bernauer W, Schuler S, Borradori L.

J Ophthalmic Inflamm Infect. 2018 Aug 23;8(1):12. doi: 10.1186/s12348-018-0153-8.

19.

Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis.

Seyed Jafari SM, Jabbary Lak F, Gazdhar A, Shafighi M, Borradori L, Hunger RE.

Eur J Dermatol. 2018 Jun 1;28(3):287-313. doi: 10.1684/ejd.2018.3291. Review.

PMID:
30105989
20.

Reply to: "Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?"

Benzaquen M, Borradori L, Cazzaniga S, Berbis P, Feldmeyer L.

J Am Acad Dermatol. 2018 Aug;79(2):e29-e30. doi: 10.1016/j.jaad.2018.03.049. No abstract available.

PMID:
30012286
21.

Factors influencing sessions' and speakers' evaluation: an analysis of seven consecutive European Academy of Dermatology and Venereology congress editions.

Cazzaniga S, Scerri L, Gabbud JP, Arenberger P, Borradori L, Naldi L.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2307-2313. doi: 10.1111/jdv.15178. Epub 2018 Aug 5.

PMID:
29992638
22.

Chronic hand eczema: A prospective analysis of the Swiss CARPE registry focusing on factors associated with clinical and quality of life improvement.

Cazzaniga S, Ballmer-Weber BK, Gräni N, Spring P, Bircher A, Anliker M, Sonntag AK, Piletta P, Huber C, Diepgen TL, Apfelbacher C, Naldi L, Borradori L, Simon D.

Contact Dermatitis. 2018 Sep;79(3):136-148. doi: 10.1111/cod.13041. Epub 2018 Jun 25.

PMID:
29943397
23.

A recessive mutation in the DSP gene linked to cardiomyopathy, skin fragility and hair defects impairs the binding of desmoplakin to epidermal keratins and the muscle-specific intermediate filament desmin.

Favre B, Begré N, Borradori L.

Br J Dermatol. 2018 Sep;179(3):797-799. doi: 10.1111/bjd.16832. Epub 2018 Jul 31. No abstract available.

PMID:
29878302
24.

Subcutaneous Injection of Large Volumes of Polidocanol.

Schibler F, Borradori L, Ramelet AA.

Dermatol Surg. 2019 Mar;45(3):476-477. doi: 10.1097/DSS.0000000000001544. No abstract available.

25.

Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30207-X. doi: 10.1016/j.jaad.2018.02.021. [Epub ahead of print]

26.

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland.

Benzaquen M, Borradori L, Berbis P, Cazzaniga S, Valero R, Richard MA, Feldmeyer L.

J Am Acad Dermatol. 2018 Jun;78(6):1090-1096. doi: 10.1016/j.jaad.2017.12.038. Epub 2017 Dec 21.

PMID:
29274348
27.

Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid.

de Graauw E, Sitaru C, Horn MP, Borradori L, Yousefi S, Simon D, Simon HU.

Allergy. 2018 May;73(5):1119-1130. doi: 10.1111/all.13376. Epub 2018 Jan 17.

PMID:
29222810
28.

The expanding spectrum of clinical phenotypes associated with PSTPIP1 mutations: from PAPA to PAMI syndrome and beyond.

Klötgen HW, Beltraminelli H, Yawalkar N, van Gijn ME, Holzinger D, Borradori L.

Br J Dermatol. 2018 Apr;178(4):982-983. doi: 10.1111/bjd.16136. Epub 2018 Feb 23. No abstract available.

29.

Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center.

Vinay K, Cazzaniga S, Amber KT, Feldmeyer L, Naldi L, Borradori L.

J Am Acad Dermatol. 2018 Apr;78(4):806-808. doi: 10.1016/j.jaad.2017.11.024. Epub 2017 Nov 13. No abstract available.

30.

Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid.

Schaffer C, Buclin T, Jornayvaz FR, Cazzaniga S, Borradori L, Gilliet M, Feldmeyer L.

Dermatology. 2017;233(5):401-403. doi: 10.1159/000480498. Epub 2017 Oct 18. No abstract available.

31.

Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases.

Houriet C, Seyed Jafari SM, Thomi R, Schlapbach C, Borradori L, Yawalkar N, Hunger RE.

JAMA Dermatol. 2017 Nov 1;153(11):1195-1197. doi: 10.1001/jamadermatol.2017.2392. No abstract available.

PMID:
28854317
32.

Eosinophils as putative therapeutic targets in bullous pemphigoid.

Simon D, Borradori L, Simon HU.

Exp Dermatol. 2017 Dec;26(12):1187-1192. doi: 10.1111/exd.13416. Epub 2017 Oct 26. Review.

33.

Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L.

Clin Rev Allergy Immunol. 2018 Feb;54(1):26-51. doi: 10.1007/s12016-017-8633-4. Review.

PMID:
28779299
34.

The Cutaneous Spectrum of Lupus Erythematosus.

Ribero S, Sciascia S, Borradori L, Lipsker D.

Clin Rev Allergy Immunol. 2017 Dec;53(3):291-305. doi: 10.1007/s12016-017-8627-2. Review.

PMID:
28752372
35.

Patterns of chronic hand eczema: a semantic map analysis of the CARPE registry data.

Cazzaniga S, Apfelbacher C, Diepgen T, Ofenloch RF, Weisshaar E, Molin S, Bauer A, Mahler V, Elsner P, Schmitt J, Ballmer-Weber BK, Spring P, Naldi L, Borradori L, Simon D; CARPE study groups of Germany and Switzerland.

Br J Dermatol. 2018 Jan;178(1):229-237. doi: 10.1111/bjd.15660. Epub 2017 Dec 6.

PMID:
28498524
36.

Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.

Page B, Borradori L, Beltraminelli H, Yawalkar N, Hunger RE.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e256-e257. doi: 10.1111/jdv.14282. Epub 2017 May 30. No abstract available.

PMID:
28430376
37.

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.

Schmidt E, Spindler V, Eming R, Amagai M, Antonicelli F, Baines JF, Belheouane M, Bernard P, Borradori L, Caproni M, Di Zenzo G, Grando S, Harman K, Jonkman MF, Koga H, Ludwig RJ, Kowalczyk AP, Müller EJ, Nishie W, Pas H, Payne AS, Sadik CD, Seppänen A, Setterfield J, Shimizu H, Sinha AA, Sprecher E, Sticherling M, Ujiie H, Zillikens D, Hertl M, Waschke J.

J Invest Dermatol. 2017 Jun;137(6):1199-1203. doi: 10.1016/j.jid.2017.01.028. Epub 2017 Apr 5. Review.

38.

Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?

Ribero S, Stucci LS, Daniels GA, Borradori L.

Curr Opin Oncol. 2017 Mar;29(2):129-135. doi: 10.1097/CCO.0000000000000359. Review.

39.

Evidence for a role of eosinophils in blister formation in bullous pemphigoid.

de Graauw E, Sitaru C, Horn M, Borradori L, Yousefi S, Simon HU, Simon D.

Allergy. 2017 Jul;72(7):1105-1113. doi: 10.1111/all.13131. Epub 2017 Mar 1.

PMID:
28135772
40.

Prurigo Pigmentosa in White Monozygotic Twins.

Houriet C, Perruchoud DL, Beltraminelli H, Borradori L.

JAMA Dermatol. 2017 Mar 1;153(3):353-354. doi: 10.1001/jamadermatol.2016.4921. No abstract available.

PMID:
28099972
41.

Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT.

Maul JT, Djamei V, Kolios AGA, Meier B, Czernielewski J, Jungo P, Yawalkar N, Mainetti C, Laffitte E, Spehr C, Anliker M, Streit M, Augustin M, Rustenbach S, Conrad C, Hafner J, Boehncke WH, Borradori L, Gilliet M, Itin P, French LE, Häusermann P, Navarini AA.

Dermatology. 2016;232(6):640-647. doi: 10.1159/000452740. Epub 2017 Jan 12.

42.

Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid.

Glauser S, Rutz M, Cazzaniga S, Hegyi I, Borradori L, Beltraminelli H.

Br J Dermatol. 2016 Nov;175(5):988-993. doi: 10.1111/bjd.14686. Epub 2016 Aug 30.

PMID:
27105821
43.

Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Kim M, Borradori L, Murrell DF.

Drugs Aging. 2016 Oct;33(10):711-723. Review.

PMID:
27738963
44.

Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus.

Weber B, Schlapbach C, Stuck M, Simon HU, Borradori L, Beltraminelli H, Simon D.

J Eur Acad Dermatol Venereol. 2017 May;31(5):880-886. doi: 10.1111/jdv.13989. Epub 2016 Oct 21.

PMID:
27696572
45.

Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases.

Borradori L, Sutton B, Shayesteh P, Daniels GA.

Br J Dermatol. 2016 Dec;175(6):1382-1386. doi: 10.1111/bjd.14642. Epub 2016 Oct 17. No abstract available.

PMID:
27059424
46.

Rituximab for the Treatment of Isolated Refractory Desquamative Gingivitis Due to Mucous Membrane Pemphigoid.

Haefliger S, Horn MP, Suter VG, Bornstein MM, Borradori L.

JAMA Dermatol. 2016 Dec 1;152(12):1396-1398. doi: 10.1001/jamadermatol.2016.3434. No abstract available.

PMID:
27732708
47.

Treatment of sporadic port-wine stains: a retrospective review of 17 cases consecutively treated by pulsed sequential dual wavelength 595 and 1064 nm laser.

Perruchoud DL, Cazzaniga S, Heidemeyer K, Weber B, Dietrich N, Borradori L, Adatto MA.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):557-563. doi: 10.1111/jdv.13975. Epub 2016 Oct 10.

PMID:
27658196
48.

The pathogenesis of pemphigus: Controversy vs complexity.

Di Zenzo G, Borradori L, Muller EJ.

Exp Dermatol. 2017 Dec;26(12):1271-1273. doi: 10.1111/exd.13176. Epub 2017 Mar 1. No abstract available.

49.

Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease.

Wilson NJ, Cole C, Kroboth K, Hunter WN, Mann JA, McLean WH, Kernland Lang K, Beltraminelli H, Sabroe RA, Tiffin N, Sobey GJ, Borradori L, Simpson E, Smith FJ.

Br J Dermatol. 2017 Jan;176(1):270-274. doi: 10.1111/bjd.14914. Epub 2016 Sep 24. No abstract available.

50.

Bowen disease of the nail unit: a retrospective study of 12 cases and their association with human papillomaviruses.

Perruchoud DL, Varonier C, Haneke E, Hunger RE, Beltraminelli H, Borradori L, Ehnis Pérez A.

J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1503-6. doi: 10.1111/jdv.13654. Epub 2016 Jul 13.

PMID:
27405962

Supplemental Content

Loading ...
Support Center